| 序号 |
标题 |
次数 |
作者 |
发布时间 |
| 75286 |
High Potency Clodronate Liposome (Neutral),高效氯膦酸盐脂质体(中性) |
125 |
axc |
2024-12-24 |
| 75287 |
Bromo-PEG7-CH2COOtBu |
96 |
h |
2024-12-24 |
| 75288 |
DiR Labeled Mannosylated Control Liposome (Neutral),DiR标记的甘露糖对照脂质体(中性) |
119 |
axc |
2024-12-24 |
| 75289 |
Bromo-PEG5-CH2COOtBu |
120 |
h |
2024-12-24 |
| 75290 |
DiD Labeled Mannosylated Control Liposome (Neutral),标记的甘露糖对照脂质体(中性) |
130 |
axc |
2024-12-24 |
| 75291 |
Bromo-PEG8-CH2COOtBu |
93 |
h |
2024-12-24 |
| 75292 |
DiA Labeled Mannosylated Control Liposome (Neutral),DiA标记的甘露糖对照脂质体(中性) |
110 |
axc |
2024-12-24 |
| 75293 |
Biotin-PEG3-CH2COOH,CAS号：1189560-96-0,生物素-PEG3-乙酸 |
172 |
h |
2024-12-24 |
| 75294 |
DiI Labeled Mannosylated Control Liposome (Neutral),DiI标记的甘露糖对照脂质体(中性) |
99 |
axc |
2024-12-24 |
| 75295 |
HO-PEG5-CH2COOH,CAS号：52026-48-9 |
97 |
h |
2024-12-24 |
| 75296 |
DiR Labeled Control Clodronate Liposome (Neutral),DiR标记的对照氯膦酸盐脂质体(中性) |
139 |
axc |
2024-12-24 |
| 75297 |
BocNH-PEG4-CH2CHO |
106 |
h |
2024-12-24 |
| 75298 |
DiD Labeled Control Clodronate Liposome (Neutral),DiD标记的对照氯膦酸盐脂质体(中性) |
101 |
axc |
2024-12-24 |
| 75299 |
m-PEG1000-CH2COOH |
146 |
h |
2024-12-24 |
| 75300 |
Benzyl-PEG2-CH2COOH,CAS号：91842-53-4 |
126 |
h |
2024-12-24 |
| 75301 |
DiA Labeled Control Clodronate Liposome (Neutral),DiA标记的对照氯膦酸盐脂质体(中性) |
112 |
axc |
2024-12-24 |
| 75302 |
Propanol-PEG6-CH2OH |
106 |
h |
2024-12-24 |
| 75303 |
DiI Labeled Control Clodronate Liposome (Neutral),DiI标记的对照氯膦酸盐脂质体(中性) |
118 |
axc |
2024-12-24 |
| 75304 |
Mannosylated Control Liposome,甘露糖对照脂质体 |
130 |
axc |
2024-12-24 |
| 75305 |
Propanol-PEG4-CH2OH,CAS号：156868-17-6 |
105 |
h |
2024-12-24 |
| 75306 |
Propanol-PEG3-CH2OH,CAS号：112935-57-6 |
110 |
h |
2024-12-24 |
| 75307 |
Mannosylated Clodronate Liposome,甘露糖基氯膦酸盐脂质体 |
174 |
axc |
2024-12-24 |
| 75308 |
Fmoc-Val-Cit-PAB，159858-22-7，抗体- 药物偶联物 |
121 |
zhn |
2024-12-24 |
| 75309 |
Propanol-PEG5-CH2OH |
91 |
h |
2024-12-24 |
| 75310 |
Control Liposome,对照脂质体 |
112 |
axc |
2024-12-24 |
| 75311 |
HO-PEG10-CH2COOH,CAS号：2250056-53-0 |
152 |
h |
2024-12-24 |
| 75312 |
Clodronate Liposome,氯膦酸盐脂质体 |
313 |
axc |
2024-12-24 |
| 75313 |
HO-PEG6-CH2COOH,CAS号：120394-66-3具体解释和潜在应用 |
170 |
h |
2024-12-24 |
| 75314 |
Amino-PEG11-CH2COOH具体解释和潜在应用 |
93 |
h |
2024-12-24 |
| 75315 |
0.5% Rhod-PE Encapsulated GL67:DOPE Liposomes,阳离子脂质体定制服务 |
130 |
axc |
2024-12-24 |
| 75316 |
Fmoc-Val-Cit-PAB，159858-22-7， 抗体- 药物偶联物 |
107 |
zhn |
2024-12-24 |
| 75317 |
HO-PEG24-CH2COOH具体解释和潜在应用 |
85 |
h |
2024-12-24 |
| 75318 |
0.5% NBD-DOPE Encapsulated GL67:DOPE Liposomes,0.5% NBD-DOPE封装的GL67:DOPE脂质体 |
104 |
axc |
2024-12-24 |
| 75319 |
m-PEG10-CH2COOH,CAS号：908258-58-2,十一氧杂三十四烷酸 |
105 |
h |
2024-12-24 |
| 75320 |
HO-PEG8-CH2COOH,CAS号：780006-30-6 |
137 |
h |
2024-12-24 |
| 75321 |
GL67:DOPE Liposomes,GL67与DOPE组成的脂质体 |
114 |
axc |
2024-12-24 |
| 75322 |
0.5% Rhod-PE Encapsulated DC-Chol:DOPE Liposomes,0.5% Rhod-PE封装的DC-Chol:DOPE脂质体 |
110 |
axc |
2024-12-24 |
| 75323 |
m-PEG9-CH2COOH,CAS号：405518-55-0 |
106 |
h |
2024-12-24 |
| 75324 |
Tos-PEG5-CH2COOtBu,CAS号：1949793-62-7 |
88 |
h |
2024-12-24 |
| 75325 |
0.5% NBD-DOPE Encapsulated DC-Chol:DOPE Liposomes,0.5% NBD-DOPE封装的DC-Chol:DOPE脂质体 |
403 |
axc |
2024-12-24 |
| 75326 |
Hydroxy-PEG4-CH2COOH,14-羟基-3,6,9,12-四氧杂癸酸,CAS号：70678-95-4 |
101 |
h |
2024-12-24 |
| 75327 |
DC-Chol:DOPE Liposomes,DC-Chol与DOPE组成的脂质体 |
184 |
axc |
2024-12-24 |
| 75328 |
Hydroxy-PEG2-CH2COOH,CAS号：51951-04-3 |
80 |
h |
2024-12-24 |
| 75329 |
0.5% Rhod-PE Encapsulated DOTMA:DOPE Liposomes,0.5% Rhod-PE包裹的DOTMA:DOPE脂质体 |
150 |
axc |
2024-12-24 |
| 75330 |
Tos-PEG3-CH2COOH,CAS号：1581248-63-6 |
87 |
h |
2024-12-24 |
齐岳微信公众号
官方微信
库存查询